[1] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[2] |
BAI Zhaofang, ZHAN Xiaoyan, YAO Qing, CHEN Simin, ZHAO Xu, XIAO Xiaohe.
Theoretical innovation and technological breakthroughs in the safety evaluation of traditional Chinese medicine: disease-syndrome-based toxicology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 6-14.
|
[3] |
MA Li’na, HU Xiaozhen, ZHENG Changhui, SUN Ying, ZHAO Xu, CAO Junling, XIAO Xiaohe.
Visual analysis of knowledge map of toxic Chinese medicine Changshan toxicity-effect transformation based the thought of “yin du wei neng”
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 25-32.
|
[4] |
GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo.
Research progress on the animal models of idiosyncratic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39.
|
[5] |
SHANG Huiying, WEI Xue, CHENG Hongbo, MA Zengchun, TU Bodan, XIAO Chengrong, LIU Xian, GAO Yue.
Hepatotoxic components in Psoraleae Fructus based on high-content screening technology
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 74-82.
|
[6] |
HE Jia, JIN Yan, ZHAO Yuyang, ZHOU Junhui, LI Xiaolin, YUAN Yuan, FU Lu.
Research progress in methods for toxicity-decreasing processing of toxic herbal traditional Chinese medicines
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1064-1070.
|
[7] |
ZHANG Bing, SA Rina, ZHANG Xiaomeng, ZHANG Dan, LIN Zhijian, WANG Yu.
Research progress in pharmacogenic cardiotoxicity
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 841-847.
|
[8] |
SA Rina, ZHANG Bing, LIN Zhijian, ZHANG Xiaomeng, WANG Yu.
Therapeutic effect of saffron against arrhythmia induced by doxorubicin in rats
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 848-857.
|
[9] |
YIN Yuling, HU Chujuan, ZHANG Xiaomeng, WANG Yu, ZHANG Bing, LIN Zhijian.
Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 858-865.
|
[10] |
YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping.
Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884.
|
[11] |
DILHUMAR Dilmurat, SHI Wei, WANG Jiabo, GAO Yuan.
Research progress in safe use of Psoralea corylifolia based on evolution of toxicity/efficacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 939-945.
|
[12] |
ZHANG Qin, ZHANG Luyong, JIANG Zhenzhou.
Research progress in safety of PPAR agonists
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 950-955.
|
[13] |
CHEN Linzhen, WANG Xuan, ZHANG Xiaomeng, MA Zhiqiang, LU Shan, WU Jiarui, ZHAO Chongjun, ZHANG Bing.
Evaluation of hepatotoxicity of periplocin based on zebrafish model
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 742-748.
|
[14] |
WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei.
Acute toxicity of proline Danshensu borneol ester in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757.
|
[15] |
NIE Yunan, ZHANG Li, SHAO Mingxiang, GAO Li, YAN Ming.
Rats safety evaluation of acteoside
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 758-762.
|